Consolidated Balance Sheets (Unaudited) - USD ($)		Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents		$ 137,393,070	$ 103,022,932
Inventories		1,985,883	3,090,923
Finance lease receivables, current – related parties		8,443,338	6,143,564
Customer loans receivable, current		16,125,086	8,484,753
Prepaid expenses and other current assets		8,372,668	10,050,005
Total current assets		202,099,828	165,905,926
Non-current assets:
Property and equipment, net		13,194,414	13,582,017
Intangible assets, net		16,218,233	19,739,276
Long-term investments		4,905,115	849,434
Goodwill, net		3,545,391	3,590,791
Finance lease receivables, non-current – related parties		4,629,047	3,420,489
Operating lease right-of-use assets		5,251,418	5,919,937
Deferred tax assets		624,564
Customer loans receivable, non-current		6,590,301	6,444,025
Long-term prepayments		4,308,810	4,099,763
Long-term investments in MCs – related parties		19,561,069	19,811,555
Other assets		15,550,402	15,442,058
Total non-current assets		94,378,764	92,899,345
Total assets		296,478,592	258,805,271
Current liabilities:
Accounts payable		14,873,829	26,531,944
Current portion of long-term loans		136,683	156,217
Notes payable, current – related parties		10,202,360	3,369,203
Income tax payable		8,000,808	8,782,930
Operating lease liabilities, current		4,060,844	3,885,812
Accrued liabilities and other current liabilities		12,054,047	21,009,009
Total current liabilities		72,420,534	92,451,270
Non-current liabilities:
Long-term loans		686,470	1,062,722
Notes payable, non-current – related parties		11,659,022	11,948,219
Deferred tax liabilities		3,515,825	6,013,565
Operating lease liabilities, non-current		1,528,972	2,444,316
Other liabilities		1,147,345	1,074,930
Total non-current liabilities		18,537,634	22,543,752
Total liabilities		90,958,168	114,995,022
Preferred stock ($0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023)	[1]
Common stock ($0.0001 par value, 400,000,000 shares authorized, 103,020,816 and 94,192,433 shares issued and outstanding as of September 30, 2024 and December 31, 2023)	[1]	10,302	9,419
Additional paid-in capital	[1]	60,825,115	36,879,281
Treasury stock receivable (270,000 shares of common stock) - related party		(2,700,000)
Retained earnings		182,923,786	142,848,732
Accumulated other comprehensive loss		(36,078,149)	(37,578,255)
Total SBC Medical Group Holdings Incorporated’s stockholders’ equity		204,981,054	142,159,177
Non-controlling interests		539,370	1,651,072
Total stockholders’ equity		205,520,424	143,810,249
Total liabilities and stockholders’ equity		296,478,592	258,805,271
Nonrelated Party [Member]
Current assets:
Accounts receivable		1,944,604	1,437,077
Current liabilities:
Advances from customers		565,495	2,074,457
Related Party [Member]
Current assets:
Accounts receivable		27,835,179	33,676,672
Current liabilities:
Advances from customers		18,994,015	23,058,175
Due to related party		$ 3,532,453	$ 3,583,523

[1] Retrospectively restated for effect of reverse recapitalization on September 17, 2024.